Clinical trial
Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia
NCT03287778 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 1, 2017
- Completion date
- December 30, 2022
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antipsychotic agents, tardive dyskinesia